State Street’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144K | Buy |
|
|||||
|
2025
Q1 | $110K | Sell |
|
|||||
|
2024
Q4 | $299K | Buy |
|
|||||
|
2024
Q3 | $340K | Sell |
|
|||||
|
2024
Q2 | $394K | Sell |
|
|||||
|
2024
Q1 | $3.45M | Buy |
|
|||||
|
2023
Q4 | $1.78M | Buy |
|
|||||
|
2023
Q3 | $2.74M | Sell |
|
|||||
|
2023
Q2 | $3.96M | Sell |
|
|||||
|
2023
Q1 | $39.6M | Buy |
|
|||||
|
2022
Q4 | $28.2M | Sell |
|
|||||
|
2022
Q3 | $49.2M | Sell |
|
|||||
|
2022
Q2 | $46.7M | Sell |
|
|||||
|
2022
Q1 | $80.8M | Buy |
|
|||||
|
2021
Q4 | $35.5M | Sell |
|
|||||
|
2021
Q3 | $46.7M | Buy |
|
|||||
|
2021
Q2 | $60M | Buy |
|
|||||
|
2021
Q1 | $56.1M | Sell |
|
|||||
|
2020
Q4 | $82.7M | Buy |
|
|||||
|
2020
Q3 | $69.9M | Buy |
|
|||||
|
2020
Q2 | $87.1M | Buy |
|
|||||
|
2020
Q1 | $62.4M | Buy |
|
|||||
|
2019
Q4 | $61.9M | Buy |
|
|||||
|
2019
Q3 | $30.3M | Buy |
|
|||||
|
2019
Q2 | $6.71M | Buy |
|
|||||
|
2019
Q1 | $5.63M | Sell |
|
|||||
|
2018
Q4 | $23.6M | Buy |
|
|||||
|
2018
Q3 | $33M | Sell |
|
|||||
|
2018
Q2 | $39.7M | Buy |
|
|||||
|
2018
Q1 | $13.3M | Buy |
|
|||||
|
2017
Q4 | $5.66M | Buy |
|
|||||
|
2017
Q3 | $6.11M | Buy |
|
|||||
|
2017
Q2 | $4.63M | Buy |
|
|||||
|
2017
Q1 | $5.97M | Buy |
|
|||||
|
2016
Q4 | $3.82M | Buy |
|
|||||
|
2016
Q3 | $3.71M | Buy |
|
|||||
|
2016
Q2 | $2.49M | Buy |
|
|||||
|
2016
Q1 | $3.22M | Buy |
|
|||||
|
2015
Q4 | $4.52M | Buy |
|
|||||
|
2015
Q3 | $3.22M | Sell |
|
|||||
|
2015
Q2 | $33.6M | Buy |
|
|||||
|
2015
Q1 | $30.2M | Buy |
|
|||||
|
2014
Q4 | $25.2M | Buy |
|
|||||
|
2014
Q3 | $19.8M | Buy |
|
|||||
|
2014
Q2 | $7.87M | Buy |
|
|||||
|
2014
Q1 | $3.36M | Sell |
|
|||||
|
2013
Q4 | $2.51M | Buy |
|